MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.2602
-0.0001
-0.04%
After Hours: 0.2646 +0.0044 +1.69% 19:59 02/20 EST
OPEN
0.2510
PREV CLOSE
0.2603
HIGH
0.2653
LOW
0.2510
VOLUME
162.79K
TURNOVER
--
52 WEEK HIGH
0.4985
52 WEEK LOW
0.2420
MARKET CAP
24.93M
P/E (TTM)
-3.3359
1D
5D
1M
3M
1Y
5Y
1D
IGC Pharma issued notice of allowance by CIPO for IGC-AD1
TipRanks · 5d ago
Weekly Report: what happened at IGC last week (0209-0213)?
Weekly Report · 6d ago
'Federal Agency Finalized Rule For CBD Medicare Coverage Pilot Program Weeks Ago, Key Hemp Stakeholder Says'- Marijuana Moment
Benzinga · 02/13 16:05
'GOP Congressman Isn't Sure Marijuana Rescheduling Is A DOJ 'Priority,' But Remains Optimistic About Progress Under Trump' - Marijuana Moment
Benzinga · 02/10 16:19
IGC Pharma expands Phase 2 CALMA trial with new clinical site
TipRanks · 02/09 14:01
Weekly Report: what happened at IGC last week (0202-0206)?
Weekly Report · 02/09 09:35
IGC Pharma reaches 70% enrollment in Phase 2 CALMA trial of IGC-AD1
TipRanks · 02/02 14:01
Weekly Report: what happened at IGC last week (0126-0130)?
Weekly Report · 02/02 09:34
More
About IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) to develop treatments for Alzheimer's and metabolic disorders. The Company's lead asset, IGC-AD1, is a cannabinoid-based therapy is in a Phase 2 trial (CALMA) for agitation in Alzheimer's dementia. The Company’s pipeline includes TGR-63, targeting amyloid plaques, and early-stage programs focused on neurodegeneration, tau proteins, and metabolic dysfunctions. The Company integrates AI to accelerate drug discovery, optimize clinical trials, and enhance patient targeting. It is also developing a Multimodal Interpretable Transformer for Alzheimer’s Disease (MINT-AD). MINT-AD leverages diverse data sources, including brain scans, genetics, lifestyle, and cognitive metrics, to produce clinically interpretable risk profiles and forecast decline trajectories.

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.